LeukoPrintTM
The first-in-class leukemia sWGS CNA service
LeukoPrint™ uses shallow whole-genome sequencing (sWGS) on bone marrow samples to identify genome-wide copy number aberrations (CNAs) and copy number neutral loss of heterozygosity (CN-LOH). It provides a cost-effective and simplified method for prompt and accurate CNA and CN-LOH profiling in patients with hematological malignancies. By incorporating it with routine diagnostic methods, LeukoPrint™ can add value to conventional cytogenetics and improve diagnostic yield.
Advantages
No in vitro culture needed
High sensitivity & reliability
Automated analysis
Professional report interpretation
An example of CNA profiling of LeukoPrintTM reveals abnormal karyotype at molecular level
LeukoPrintTM Karyotyping
How it works
Customer order
Customers can place orders through SeekIn official website or local agents
Blood-draw
2ml bone marrow collected in EDTA tubes and ransport under refrigeration
Testing
Detection by next generation sequencing (NGS) platform
Reporting
The test results will be ready in about 10 workdays after your blood draw arrived at central lab
